This review paper highlights preclinical and clinical studies indicating that GLP-1 drugs, including low dose formulations such as exenatide, may offer neuroprotective benefits by targeting hallmarks of brain aging through enhancing DNA repair, boosting antioxidant responses, reducing inflammation and improving mitochondrial function
Qsymia is suitable for individuals with a body mass index (BMI) of 30 kg/m2 (obese) and those with a BMI of 27 kg/m2 (overweight) who have at least one weight-related health problem, such as high blood pressure, high blood sugar levels, or high cholesterol
NZ Drug Foundation drug checking machines can test for over 30,000 different substances, but peptides have been hard to detect because of their molecule make up, Hughes says
And, the issue here is that once you reach a target body weight, the indication for the medication should, in theory, not be present anymore
Transferrin Receptor Is a Specific Ferroptosis Marker
The crackdown that began in late 2023 saw nearly twenty of the most popular peptides, such as BPC-157 and Thymosin Alpha-1, abruptly moved to Category 2